We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Accelerated Technology Laboratories, Inc. (ATL) and Institute for Biopharmaceutical Research (IBR, Inc.) Partner to Provide Pipette Calibration Solutions for GLP and GMP Compliant Laboratories

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Accelerated Technology Laboratories, Inc. (ATL), a premier supplier of Laboratory Data Management Solutions, has announced a new partnership with Institute for Biopharmaceutical Research (IBR, Inc.) - a leader in turnkey calibration software.  

ATL is the North American Partner for IBR and will be offering Check&Track v2.0 to GLP and GMP compliant laboratories. Check&Track v2.0 offers just-in-time management of certification and recordkeeping for pipettes, specific to ISO 9000, ISO 8655, DIN 12650 and NCCLS requirements. Key benefits of this technology include automatic collection of data from an RS232 balance, automatic calibration procedures (manufacturer specific and custom macros), guided data collection during calibration, online input for environmental parameters, automatic statistics and qualification according to the specifications of the manufacturer, complete pipette history, schedules for pipette's calibration and balance service administration.  

"ATL is excited for the opportunity to team up with IBR for tighter integration of our complementary
products. They share our passion for automation and providing best-of-class tools, allowing customers to be more productive and efficient," said Dr. Christine Paszko, ATL's Vice President of Sales and Marketing.

"IBR is proud having found ATL as a highly professional partner for his software Check &Track and appreciates the fascinating collaboration dedicated to convert emerging needs in the quality managed laboratory to sophisticated products," said Dr. René Moser, IBR's CEO and CSO.